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Background: Laparoscopic spleen-preserving distal pancreatectomy is gaining acceptance for the treat-
ment of insulinomas of the pancreatic body and tail. The aim of this report is to evaluate the feasibility,
safety and outcomes of this procedure in a retrospective series.
Methods: From May 2004 to November 2013, 9 patients underwent laparoscopic spleen-preserving
distal pancreatectomy for benign insulinomas in our department. Tumors were single and sporadic in
eight patients, while the remaining patient had insulinomas in the setting of multiple endocrine
neoplasia type 1. Tumors were located by preoperative imaging in all cases. Laparoscopic ultrasound was
always performed to guide the surgical procedure.
Results: All the operations were carried out laparoscopically with a mean operative time of 110 min
(range 90e210 min) and a mean blood loss of 50 ml (range 30e120 ml). One patient (11.1%) died on the
22nd post-operative day for massive intra-abdominal bleeding associated with pancreatitis of the stump.
Two patients (22.2%) developed pancreatic ﬁstula that healed conservatively. Mean postoperative hos-
pital stay was 7.1 days (range 5e18 days). All alive patients were free from recurrence after a mean
follow-up of 45 months (range 11e72 months).
Conclusion: Laparoscopic spleen-preserving distal pancreatectomy is safe and feasible for the manage-
ment of benign insulinomas. Deﬁnition of the tumor with preoperative imaging and laparoscopic ul-
trasound is essential to achieve high cure rate with minimal conversion.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Pancreatic insulinomas (PIs) are the most common functioning
neuroendocrine tumors, with an incidence of approximately one to
four cases per million persons [1]. Surgical resection is the treat-
ment of choice for PIs, with cure being achieved inmore than 90% of
patients [2,3]. Surgical approaches include enucleation, partial or
total pancreatic resection, and pancreaticoduodenectomy. Distal
pancreatectomy is indicated for non-enucleable lesions of the
pancreatic body and tail, and can be performed with or without
spleen preservation [4]. The general features of PIs, including small
size, high benignity rate, usually sporadic nature and elective
localization in the pancreatic body and tail, make these tumors well
suitable for laparoscopic treatment [5,6]. With advances in tech-
niques and equipment, including the availability of laparoscopiclli.it (F. Corcione).
by Elsevier Ltd. All rights reservedultrasound, the minimally invasive approach to distal pancreatec-
tomy has become a feasible and safe option over the last few years
[7,8]. The aim of this paper is to report our experience with lapa-
roscopic spleen-preserving distal pancreatectomy for insulinomas,
evaluating the feasibility, safety and outcomes of this procedure.
2. Methods
From May 2004 to November 2013, 9 patients underwent
laparoscopic spleen-preserving distal pancreatectomy for insuli-
noma in our department. They were identiﬁed by a search of a
prospectively maintained operating room database. Data were
retrospectively collected from hospital charts and operative re-
ports. There were ﬁve women and four men with a mean age of
36 years (range 28e59 years). Three patients were ASA 1, 4 were
ASA 2 and 2 were ASA 3. All tumors were located preoperatively
by a combination of imaging techniques, including computed
tomography, magnetic resonance imaging, 111In-pentetreotide
scintigraphy (octreoscan) and endoscopic ultrasound. Mean size.
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pected to be benign. One patient was affected by multiple endo-
crine neoplasia type 1 and had two 25-mm insulinomas located in
the pancreatic tail and other smaller tumors in the body. The
remaining 8 patients underwent surgery for single and sporadic
insulinomas. Five tumors were located in the tail of the pancreas
and 3 in the body.
2.1. Surgical technique
The patient is placed supine in a reverse Trendelenburg position
with 10-degree right lateral tilt and legs abducted. The surgeon
stands between the patient's legs with the two assistants on each
side. Pneumoperitoneum is created via the open Veres-assisted
technique [9] and insufﬂation pressures are set at 12 mmHg. A
30 telescope is used and four trocars are placed: a 10- to 12-mm
telescope trocar (T1) in the midline above the umbilical scar; one
10- to 12-mm trocar along the left (T2) and one 5-mm trocar along
the right (T3) midclavear lines, lateral to the rectus muscles, 3 cm
above T1; one 5-mm trocar (T4) in the midline below the xiphoid
process. At ﬁrst, intraoperative ultrasonography is performed to
conﬁrm location and size of the insulinoma and to exclude addi-
tional tumors. The gastrocolic ligament is opened to allow entry
into the lesser sac and to expose the anterior surface of the
pancreas. The inferior short gastric vessels are divided only if
necessary to retract the stomach and improve exposure. At this
time, laparoscopic ultrasound is performed again to obtain precise
information about the anatomic relation of the tumor with the
Wirsung duct and major vessels, and to determine the pancreatic
resection margin. The anterior inferior surface of the pancreas is
dissected free from the attachment of the transverse mesocolon,
and the splenocolic ligament is divided to reﬂect the colon inferi-
orly. Sharp and blunt dissection of the inferior pancreatic margin
proceeds from medial to lateral towards the splenic hilum, where
the splenic vein is identiﬁed. Then the vein is dissected free from
the posterior surface of the pancreas using a lateral-to-medial
approach, with dissection moving from the splenic hilum to the
pancreatic section margin. The pancreatic branches of the vein are
sequentially identiﬁed and ligated using bipolar forceps, ultrasound
scalpel or clips. The pancreatic body and tail are further elevated to
visualize the splenic artery, which runs just superior to the vein and
is dissected free in a similar fashion. Once an adequatemobilization
of the pancreas has been achieved, a linear stapler covered by a
staple line reinforcement is applied across the pancreatic paren-
chima sparing the main splenic vessels. The pancreatic remnant is
then covered by a hemostatic patch. A drain is placed at the stapled
pancreas, and the surgical specimen is removed through a minimal
enlargement of the T1 site using a retrieval bag.
Amylase content in the drain ﬂuid was determined on post-
operative days 1, 3 and 5. Pancreatic ﬁstula was deﬁned as an
amylase value more than 2000 UI/l.
3. Results
Successful laparoscopic resection was carried out in all patients
without need for conversion or resection of the spleen. Mean
operative time was 110 min (range 90e210 min). No intraoperative
mortality was recorded. Intraoperative complications included a
bleeding from a pancreatic branch of the splenic vein that was
controlled by clip placement. Mean intraoperative blood loss was
50 ml (range 30e120 ml). Postoperative mortality was 11.1%. One
patient was discharged after a 6-day uneventful postoperative
course. He was readmitted on the 22nd postoperative day and
underwent reoperation for massive intra-abdominal bleeding
associated with pancreatitis of the stump. Unfortunately, he diedshortly after surgery. Postoperative complications included two
pancreatic ﬁstulas, accounting for an incidence rate of 22.2%. They
were low-output ﬁstulas with associated pleural collections that
healed with conservative management, including total parenteral
nutrition, persisting drainage and octreotide perfusion. Transient
hyperamilasemia was recorded in two patients. Mean post-
operative hospital stay was 7.1 days (range 5e18 days). All insuli-
nomas were benign at the ﬁnal pathologic examination. All alive
patients were free from recurrence after a mean follow-up of 45
months (range 11e72 months).
4. Discussion
Since the ﬁrst description by Gagner in 1996 [10], the laparo-
scopic treatment of PIs is gaining wide acceptance. However,
feasibility and safety of this approach have been reported only in a
small number of patients, mainly due to the rarity of this tumor and
to the need of very skilled surgeons [11e15]. A recent meta-analysis
including seven studies with a total of 452 patients found that the
laparoscopic approach for PIs is associated with reduction of hos-
pital stay and similar rates of postoperative complications
compared to open surgery [6].
Patients with benign tumors located in the body or tail of the
pancreas can better beneﬁt from the laparoscopic approach. For
this location, either distal pancreatectomy or tumor enucleation
can be correctly employed [11]. The size of the tumor and the
relationship with the pancreatic duct and splenic vessels as well as
the occurrence of multiple lesions are crucial in determining the
surgical procedure [4,16,17]. Laparoscopic intraoperative ultraso-
nography is the most effective technique to assess these issues
[18,19]. Furthermore, it is essential to precisely determine the
pancreatic resection line, in order to assure a complete tumor
excision. For these reasons, the availability of intraoperative ultra-
sound should be considered essential for guidance of the laparo-
scopic approach [19]. The use of this imaging modality may also
help to signiﬁcantly reduce the need for conversion. Inability to
localize the tumor has been reported as the main reason for con-
version, together with technical difﬁculties in performing pancre-
atic resection [19,20]. Conversion rates in the literature vary from
20 to 33% [6], but in our series no conversion occurred.
Distal pancreatectomy is the procedure of choice for insulino-
mas of the pancreatic body and tail located deeply in the paren-
chima and close to the main pancreatic duct [15]. Recent literature
conﬁrms that laparoscopic distal pancreatectomy is a feasible and
safe procedure in patients with benign or low grade malignancies
[7]. Two major issues related to this procedure are preserving the
spleen and controlling the leak from the pancreatic stump.
As with open surgery, spleen preservation is encouraged
whenever it is technically feasible, although reported experiences
are limited [15,21,22]. It is advocated given the lack of oncologic
reasons for removing the lymphatics along the splenic vessels and
the lymph nodes in the splenic hilum [22]. Moreover, spleen
preservation has been reported to be associated with a reduction in
perioperative infections and severe complications [23]. Preserva-
tion of the spleen with distal pancreatectomy can be achieved by
carefully dissecting the pancreas off the splenic vessels or by
maintaining the blood to the spleen via short gastric vessels, with
resection of the splenic artery and vein (Warshaw's technique). The
latter procedure may shorten operative time and reduce blood loss
as well as the incidence of massive bleeding from injury to the
splenic vessels [24,25]. Although Warshaw's technique has been
reported for PIs [26], these advantages may be less evident for
patients with small and benign tumors like PIs, especially if not
located close to the splenic vessels. Moreover, this procedure may
be associated with postoperative splenic infarction requiring
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bleeding from gastric and perigastric varices [22,27,28]. Preserva-
tion of the splenic vessels should be always attempted, and a
careful blunt dissection together with the appropriate use of
modern technologies is the key to achieve it. The short gastric
vessels should be preserved during the operation, in order to allow
a “conversion” to Warshaw's technique in case of a very difﬁcult
dissection or accidental bleeding [29]. In our experience, we per-
formed this procedure only twice for large pancreatic
cistoadenoma close to the splenic vessels. In both cases, the post-
operative course was complicated by splenic infarction.
Pancreatic ﬁstula is the other major issue regarding distal
pancreatectomy. It remains the most common postoperative
complication, with an incidence rate up to more than 27% [30].
Recent comparative studies and meta-analysis found that the
laparoscopic approach is associated with similar rates of ﬁstula
compared to open surgery [6,31,32]. However, a limitation is that
variation exists in the deﬁnition of pancreatic ﬁstula among the
studies. Several surgical techniques and devices for management of
the pancreatic stump have been proposed to prevent leakage,
including stapler, sutures, radiofrequency or ultrasonic devices,
ﬁbrin glue, sealants and patches, but without any signiﬁcant
improvement [33e35]. The incidence of pancreatic ﬁstula seems to
be related neither to themethod of stump closure nor to underlying
pathologic process [36]. In our series ﬁstula occurred in 22.2% of
patients and none of them required reoperation.
In conclusion, laparoscopic spleen-preserving distal pancrea-
tectomy can be safely performed in most patients with benign
insulinomas. Deﬁnition of the tumor with preoperative imaging
and laparoscopic ultrasound is essential to achieve high cure rate
with minimal conversion. Additional researches are needed to
reduce the incidence of pancreatic ﬁstula.Ethical approval
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